Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson’s disease
Evan H. Howlett, Nicholas O. Jensen, Frances Belmonte, et al.
Human Molecular Genetics (2017) Vol. 26, Iss. 22, pp. 4340-4351
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
Preston Ge, Valina L. Dawson, Ted M. Dawson
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 373
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
Xiansi Zeng, Wen-Shuo Geng, Jing Jia, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 178
The Genetics of Parkinson’s Disease and Implications for Clinical Practice
Jacob Day, Stephen Mullin
Genes (2021) Vol. 12, Iss. 7, pp. 1006-1006
Open Access | Times Cited: 152
Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
Jenne Tran, Helena Targa Dias Anastacio, Cédric Bardy
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 143
Metabolic alterations in Parkinson’s disease astrocytes
Tuuli-Maria Sonninen, Riikka H. Hämäläinen, Marja Koskuvi, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 142
Axonal energy metabolism, and the effects in aging and neurodegenerative diseases
Sen Yang, Jung Hyun Park, Hui‐Chen Lu
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 43
A blood-based marker of mitochondrial DNA damage in Parkinson’s disease
Rui Qi, Esther Sammler, Claudia P. González-Hunt, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 711
Open Access | Times Cited: 43
The Role of the Antioxidant Response in Mitochondrial Dysfunction in Degenerative Diseases: Cross-Talk between Antioxidant Defense, Autophagy, and Apoptosis
Michael Huang, Shannon Chiang, Danuta S. Kalinowski, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-26
Open Access | Times Cited: 121
LRRK2 and mitochondria: Recent advances and current views
Alpana Singh, Lianteng Zhi, Hui Zhang
Brain Research (2018) Vol. 1702, pp. 96-104
Open Access | Times Cited: 110
DNA damage by oxidative stress: Measurement strategies for two genomes
Claudia P. González-Hunt, Mandheer Wadhwa, Laurie H. Sanders
Current Opinion in Toxicology (2018) Vol. 7, pp. 87-94
Closed Access | Times Cited: 102
Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
Noha Gouda, Ahmed Elkamhawy, Jungsook Cho
Biomedicines (2022) Vol. 10, Iss. 2, pp. 371-371
Open Access | Times Cited: 57
LRRK2 and Parkinson's disease: from genetics to targeted therapy
Yuri L. Sosero, Ziv Gan‐Or
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 6, pp. 850-864
Open Access | Times Cited: 30
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
Jiarui Hu, Dan Zhang, Keyue Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115475-115475
Closed Access | Times Cited: 27
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
Yahaira Naaldijk, Belén Fernández, Rachel Fasiczka, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage
Nicholas Pena, Tara Richbourg, Claudia P. González-Hunt, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
LONG-RANGE PCR AS A TOOL FOR EVALUATING MITOCHONDRIAL DNA DAMAGE: PRINCIPLES, BENEFITS, AND LIMITATIONS OF THE TECHNIQUE
Artem P. Gureev, Veronika V. Nesterova, Irina S. Sadovnikova
DNA repair (2025) Vol. 146, pp. 103812-103812
Closed Access | Times Cited: 1
LRRK2 Kinase Activity Induces Mitochondrial Fission in Microglia via Drp1 and Modulates Neuroinflammation
Dong Hwan Ho, A Reum Je, Hae-Jin Lee, et al.
Experimental Neurobiology (2018) Vol. 27, Iss. 3, pp. 171-180
Open Access | Times Cited: 80
LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia
Judong Kim, Edward Pajarillo, Asha Rizor, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0210248-e0210248
Open Access | Times Cited: 71
DNA damage and repair in Parkinson's disease: Recent advances and new opportunities
Claudia P. González-Hunt, Laurie H. Sanders
Journal of Neuroscience Research (2020) Vol. 99, Iss. 1, pp. 180-189
Closed Access | Times Cited: 55
Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
Paula Ramos-Gonzalez, Susana Mato, Juan Carlos Chara, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 49
Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo
Jillian H. Kluss, Melissa Conti Mazza, Yan Li, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 45
The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention
Stephanie M. Boas, Kathlene L. Joyce, Rita M. Cowell
Antioxidants (2021) Vol. 11, Iss. 1, pp. 8-8
Open Access | Times Cited: 43
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
Yashumati Ratan, Aishwarya Rajput, Ashutosh Pareek, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 73-73
Open Access | Times Cited: 7
Recent Developments in LRRK2-Targeted Therapy for Parkinson’s Disease
Ye Zhao, Nicolas Dzamko
Drugs (2019) Vol. 79, Iss. 10, pp. 1037-1051
Closed Access | Times Cited: 50
The multiple roles of exosomes in Parkinson's disease: an overview
Chiara Porro, Maria Antonietta Panaro, Dario Domenico Lofrumento, et al.
Immunopharmacology and Immunotoxicology (2019) Vol. 41, Iss. 4, pp. 469-476
Closed Access | Times Cited: 49
Page 1 - Next Page

Scroll to top